NOSOTEQ

Welcome to the Brand page for “NOSOTEQ”, which is offered here for Monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular staphylococcal epidermidis and staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular staphylococcal epidermidis and staphylococcal aureus;.

Its status is currently believed to be active. Its class is unavailable. “NOSOTEQ” is believed to be currently owned by “GLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A.”


Owner:
GLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A.
Owner Details
Description:
Monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus;
Categories: MONOCLONAL ANTIBODIES TREATMENT